Description

Talizumab CAS NO 380610-22-0 is a high-purity monoclonal antibody or advanced pharmaceutical intermediate designed for research and development applications. This compound is critical for advancing therapeutic programs in immunology and oncology, offering a reliable building block for drug discovery and formulation studies. It is primarily utilized by pharmaceutical companies, biotechnology research firms, and academic institutions engaged in the development of targeted biologic therapies.

Application

• Pharmaceutical R&D: Serves as a key intermediate or reference standard in the development of novel monoclonal antibody-based therapeutics.
• Immunological Research: Used in preclinical studies to investigate mechanisms of action, target binding, and efficacy in disease models.
• Bioconjugation Studies: Acts as a substrate for developing antibody-drug conjugates (ADCs) or other modified biologic constructs.
• Quality Control & Analytical Development: Employed as a reference material for method validation, assay calibration, and purity assessment in QC laboratories.
• Process Development: Utilized in upstream and downstream process optimization for biologic manufacturing.
• Diagnostic Reagent Development: Can be used in the formulation of high-sensitivity immunoassays and diagnostic kits.

Basic Information

Product Name	Talizumab
CAS No.	380610-22-0
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Talizumab; Anti-IL-13 monoclonal antibody; IL-13 inhibitor; CAT-354; Antibody CAT-354; Therapeutic monoclonal antibody; Immunoglobulin G1, anti-(human interleukin 13); Biologic agent CAT-354
EINECS	Contact for details

Quality Control

Our Talizumab is produced under a rigorous quality management system. Each batch undergoes comprehensive analytical testing to ensure identity, purity, potency, and consistency. Certificates of Analysis (COA) documenting specifications such as purity by HPLC, biological activity, endotoxin levels, and sterility (where applicable) are provided. We adhere to cGMP guidelines for pharmaceutical intermediates to support our clients' regulatory submissions.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below for long-term stability. This product is strictly light-sensitive (protect from all light exposure) and hygroscopic (moisture-sensitive). For short-term use, aliquoting is recommended to avoid repeated freeze-thaw cycles. Store in a dry, cool, and well-ventilated place away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder or clear solution
Identification (HPLC/MS)	Conforms to reference standard
Purity (HPLC)	≥ 95.0%
Protein Content	As per COA
Biological Activity	As per COA
Endotoxin	< 1.0 EU/mg
Sterility (if supplied sterile)	Sterile
Solubility	Soluble in appropriate aqueous buffers

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.